ArticleClinical pharmacology in drug development2021

Evaluation of Drug-Drug Interaction Liability for Buprenorphine Extended-Release Monthly Injection Administered by Subcutaneous Route.

Jahnavi Kharidia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.